Results 201 to 210 of about 82,726 (255)

Targeting neutrophil extracellular traps in metabolic and immune niche: Nanomaterials for diabetes tissue regeneration

BMEMat, EarlyView.
The effects of NETs on regeneration of various diabetic tissues, and strategies targeting NETs for diabetes tissue regeneration. In the diabetic environment, NETs undergo complex metabolic and immune reprogramming, leading to dynamic changes in antibacterial and proinflammatory functions, and affecting regeneration of multiple systemic tissues.
Xinyi Jiang, Muxin Yue, Kai Mao, Boon Chin Heng, Noor Azlin Yahya, Yunsong Liu, Zheng Li   +6 more
wiley   +1 more source

Role of serum complement C3 and C4 on kidney outcomes in IgA nephropathy. [PDF]

Sci Rep
Tringali E, Vetrano D, Tondolo F, Maritati F, Fabbrizio B, Pasquinelli G, Provenzano M, La Manna G, Baraldi O.   +8 more
europepmc   +1 more source

Tackling cancer stemness with nanotechnology in the era of precision medicine

BMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo, Shun Yao, Lihui Meng, Chunyuan Chen, Yuechu Lucinda Lu, Rong Lu, Kashif Rafiq Zahid, Umar Raza, Qingzhi Wu, Wenli Chen   +9 more
wiley   +1 more source

Complement C3 deposition restricts the proliferation of internalized <i>Staphylococcus aureus</i> by promoting autophagy. [PDF]

Front Cell Infect Microbiol
Deng Y, Zhang Y, Wu T, Niu K, Jiao X, Ma W, Peng C, Wu W.   +7 more
europepmc   +1 more source

Harnessing blood clot as a native scaffold for orchestrating tissue repairs and regeneration

BMEMat, EarlyView.
The blood clot, owing to its dynamic composition and unique microenvironment, holds significant yet underappreciated potential for tissue engineering. This review systematically summarizes the pathophysiology of clot formation, the key regulatory factors shaping its microenvironment, and its applications in both pre‐clinical and clinical settings ...
Gao‐peng Dang, Yu‐zhu Wang, Yi‐fei Wang, Que Bai, Jia‐xin Hao, Zhi‐ting Li, Xiao‐qing Cao, Yu Wei, Yue Feng, Ji‐hua Chen, Franklin R. Tay, Rui‐bing Wang, Jun‐ting Gu, Li‐na Niu   +13 more
wiley   +1 more source

Acute depletion of complement C3 with cobra venom factor attenuates memory deficits induced by status epilepticus. [PDF]

Epilepsia Open
Schartz ND, Li Y, Sommer AL, Brewster AL.   +3 more
europepmc   +1 more source

Complement C3 promotes islet β-cell dedifferentiation by activating Wnt/β-catenin pathway. [PDF]

iScience
Zhuang L, Li Q, You W, Wen S, Chen T, Su J, Zhao W, Hu J.   +7 more
europepmc   +1 more source

The relationship between serum CTRP-5, C3a/desArg, and complement-C3 levels and hypothyroidism in women with polycystic ovary syndrome. [PDF]

BMC Endocr Disord
Abdul-Ameer F, AlAsadi IJA, Hosseini A, Bahreini E.   +3 more
europepmc   +1 more source

Complement C3 is downregulated following ranibizumab intervention in experimental central retinal vein occlusion. [PDF]

Mol Vis
Cehofski LJ, Kruse A, Mæng MO, Kjaergaard B, Sejergaard BF, Schlosser A, Sorensen GL, Honoré B, Vorum H.   +8 more
europepmc   +1 more source

Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragments covalently deposited on lymphoma cells.

Blood
Baskar S, Peng H, Gaglione EM, Carstens EJ, Lindorfer MA, Ahn IE, Herman SEM, Skarzynski M, Chang J, Keyvanfar K, Butera V, Blackburn A, Vire B, Maric I, Stetler-Stevenson M, Yuan CM, Eckhaus MA, Soto S, Farooqui MZH, Taylor RP, Rader C, Wiestner A.   +21 more
europepmc   +1 more source